Michael Matson
Stock Analyst at Needham
(1.75)
# 1,966
Out of 4,842 analysts
23
Total ratings
33.33%
Success rate
7.05%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Buy | $408 → $423 | $121.09 | +249.33% | 4 | Jan 31, 2020 | |
| INGN Inogen | Upgrades: Buy | $90 | $6.56 | +1,271.95% | 2 | Nov 6, 2019 | |
| MMSI Merit Medical Systems | Initiates: Buy | $53 | $94.51 | -43.92% | 1 | Apr 20, 2018 | |
| GMED Globus Medical | Upgrades: Buy | n/a | $59.21 | - | 1 | Apr 4, 2018 | |
| RMD ResMed | Upgrades: Hold | n/a | $244.76 | - | 1 | Jan 23, 2018 | |
| BSX Boston Scientific | Upgrades: Strong Buy | n/a | $104.51 | - | 1 | Dec 8, 2017 | |
| LIVN LivaNova | Upgrades: Buy | n/a | $42.82 | - | 2 | Sep 15, 2017 | |
| SYK Stryker | Upgrades: Hold | n/a | $380.39 | - | 4 | Aug 25, 2017 | |
| MBLY Mobileye Global | Downgrades: Hold | n/a | $16.82 | - | 1 | Mar 14, 2017 | |
| HOLX Hologic | Upgrades: Buy | n/a | $63.71 | - | 2 | Feb 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $66.33 | - | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.54 | - | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.38 | - | 1 | Feb 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $38.58 | - | 1 | Jan 29, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $121.09
Upside: +249.33%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $6.56
Upside: +1,271.95%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $94.51
Upside: -43.92%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $59.21
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $244.76
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $104.51
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $42.82
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $380.39
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $16.82
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $63.71
Upside: -
Aug 12, 2016
Downgrades: Hold
Price Target: n/a
Current: $66.33
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $1.54
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $1.38
Upside: -
Jan 29, 2016
Upgrades: Buy
Price Target: n/a
Current: $38.58
Upside: -